Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 17, 2014
Horizon Discovery Group plc (LSE: HZD) (Horizon), a leading provider of research tools to support translational genomics, , has today announced the formation of a new Scientific Advisory Board (SAB) for its Diagnostics Business Unit (Horizon ...
read more
goBalto announced that Worldwide Clinical Trials has chosen goBalto's end-to-end platform for starting clinical trials.
read more
Monday, November 20, 2023
AstraZeneca has unveiled Evinova, a cutting-edge digital health solutions provider aimed at addressing the diverse needs of healthcare professionals, regulatory bodies, and patients. With steadfast support from AstraZeneca and strategic partnerships ...
read more
ADMA Biologics announced the commencement of operations and initiation of collections at its newest ADMA BioCenters plasma collection facility located in Knoxville, TN.
read more
Unique Pharmaceuticals, a 503B current Good Manufacturing Practices (CGMP) Outsourcing Facility, has announced its licensure approval in Florida.
read more
Scinai Biopharma Services has appointed Eilon Elmalem as site head of the company’s Yavne CDMO facility, effective June 14, 2026.
read more
LaunchWorks announced that it has increased its filling capacity for the production of diagnostic test kits with the addition of new automation equipment at its Beverly, MA and Anjou, Canada facilities.
read more
Pfizer has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net in cash (without interest but subject to ...
read more
PhaseBio announced a financing and co-development collaboration with SFJ Pharmaceuticals to support the development of PB2452, a reversal agent for the antiplatelet therapy ticagrelor.
read more
Three top executives from Theorem Clinical Research
will be on the agenda at the 23rd Annual Partnerships in Clinical Trials in Las Vegas, March 31-
April 2.
read more
Tuesday, November 03, 2015
PharPoint Research, Inc., a contract research organization (CRO), has announced that the stable growth of new employees has led to the expansion of their Wilmington, NC office.
read more
Thursday, August 28, 2025
Atossa Therapeutics has selected PSI to operationalize and manage its planned (Z)-endoxifen monotherapy dose-ranging study in women with metastatic breast cancer (mBC). The study was designed following guidance from the FDA and is intended to ...
read more
Monday, September 30, 2019
Horizon Discovery Group announced the full commercial licensing to Glenmark of its gene-edited Glutamine Synthetase knockout Chinese Hamster Ovary K1 cell line.
read more
Wednesday, October 19, 2016
ATCC, a global provider of biological materials development, management and standards, and BioAgilytix, a provider of contract testing services with a specialization in biologics, have announced a strategic partnership to develop new and custom cell-...
read more
Monday, September 21, 2020
Mylan and Pfizer announced the companies have received final approval from the EC for the proposed combination of Mylan and Pfizer's Upjohn business.
read more